(June 6, 2016, 12:34 PM EDT) -- WASHINGTON, D.C. — In its June 6 orders list, the U.S. Supreme Court invited the U.S. solicitor general to weigh in on a patent and antitrust dispute involving the epilepsy drug Lamictal (SmithKline Beecham Corp., et al. v. King Drug Company of Florence Inc., No. 15-1055, U.S. Sup.)....